Serial 98662016
Live / Allowed — Third extension granted (statement of use) (as of 03 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98662016
- Mark type
- Design / logo
- Filed
- 23 Jul 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Tamar Niv Bessinger
Goods and services
- Class 005 — Pharmaceuticals: Antiviral pharmaceuticals; immunotherapy pharmaceuticals; antiviral pharmaceuticals for use in the treatment of infectious diseases and disorders and in the field of oncology
Owner
- Vir Biotechnology, Inc., San Francisco, CA, US
- Vir Biotechnology, Inc., San Francisco, CA, US
Prosecution history
- 04 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2026 — SOU EXTENSION 3 GRANTED
- 28 Aug 2026 — SOU EXTENSION 3 FILED
- 28 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2026 — SOU EXTENSION 2 GRANTED
- 29 Apr 2026 — SOU EXTENSION 2 FILED
- 29 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Apr 2026 — SOU EXTENSION 1 GRANTED
- 22 Sept 2025 — SOU EXTENSION 1 FILED
- 09 Apr 2026 — CORRECTED NOA E-MAILED
- 09 Apr 2026 — DIVISIONAL PROCESSING COMPLETE
- 22 Sept 2025 — DIVISIONAL REQUEST RECEIVED
- 06 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL